Daytime napping, sleep duration and serum C reactive protein: A population-based cohort study

BMJ Open

Volumn 4, Issue 11, 2014, Pages

  Leng, Yue ^a   Ahmadi Abhari, Sara ^a   Wainwright, Nick W J ^a   Cappuccio, Francesco P ^b   Surtees, Paul G ^a   Luben, Robert ^a   Brayne, Carol ^c   Khaw, Kay Tee ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; C REACTIVE PROTEIN; HYPNOTIC AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; BODY MASS; CIRCADIAN RHYTHM; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DAYTIME NAPPING; DAYTIME SOMNOLENCE; DEPRESSION; EDUCATIONAL STATUS; FEMALE; GEOMETRY; HORMONE SUBSTITUTION; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PHYSICAL ACTIVITY; POPULATION BASED CASE CONTROL STUDY; PREDICTIVE VALUE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; SERUM; SEX DIFFERENCE; SLEEP DEPRIVATION; SLEEP PARAMETERS; SLEEP PATTERN; SLEEP TIME; SMOKING; SOCIAL CLASS; SYSTOLIC BLOOD PRESSURE; HABIT; MIDDLE AGED; QUESTIONNAIRE; SLEEP; TIME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HABITS; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; SLEEP; TIME FACTORS;

EID: 84911906474     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006071     Document Type: Article

References (45)

1. Milner C, Cote KA. Benefits of napping in healthy adults: impact of nap length, time of day, age, and experience with napping. J Sleep Res 2009;18:272-81.
2. Bursztyn M, Stessman J. The siesta and mortality: twelve years of prospective observations in 70-year-olds. Sleep 2005;28:345-7.
3. Jung K-I, Song C-H, Ancoli-Israel S, et al. Gender differences in nighttime sleep and daytime napping as predictors of mortality in older adults: the Rancho Bernardo study. Sleep Med 2013;14:12-19.
4. Tanabe N, Iso H, Seki N, et al. Daytime napping and mortality, with a special reference to cardiovascular disease: the JACC study. Int J Epidemiol 2010;39:233-43.
5. Xu Q, Song Y, Hollenbeck A, et al. Day napping and short night sleeping are associated with higher risk of diabetes in older adults. Diabetes Care 2010;33:78-83.
6. Leng Y, Wainwright NWJ, Cappuccio FP, et al. Daytime napping and the risk of all-cause and cause-specific mortality: a 13-year follow-up of a British population. Am J Epidemiol 2014;179:1115-24.
7. Mullington JM, Simpson NS, Meier-Ewert HK, et al. Sleep loss and inflammation. Best Pract Res Clin Endocrinol Metab 2010;24:775-84.
8. Meier-Ewert HK, Ridker PM, Rifai N, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004;43:678-83.
9. Jackowska M, Kumari M, Steptoe A. Sleep and biomarkers in the English Longitudinal Study of Ageing: associations with C-reactive protein, fibrinogen, dehydroepiandrosterone sulfate and hemoglobin. Psychoneuroendocrinology 2013;38:1484-93.
10. Patel SR, Zhu X, Storfer-Isser A, et al. Sleep duration and biomarkers of inflammation. Sleep 2009;32:200-4.
11. Dowd JB, Goldman N, Weinstein M. Sleep duration, sleep quality, and biomarkers of inflammation in a Taiwanese population. Ann Epidemiol 2011;21:799-806.
12. Grandner MA, Buxton OM, Jackson N, et al. Extreme sleep durations and increased C-reactive protein: effects of sex and ethnoracial group. Sleep 2013;36:769-79E.
13. Miller MA, Kandala N-B, Kivimaki M, et al. Gender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II study. Sleep 2009;32:857-64.
14. Taheri S, Austin D, Lin L, et al. Correlates of serum C-reactive protein (CRP)-no association with sleep duration or sleep disordered breathing. Sleep 2007;30:991-6.
15. Faraut B, Boudjeltia KZ, Dyzma M, et al. Benefits of napping and an extended duration of recovery sleep on alertness and immune cells after acute sleep restriction. Brain Behav Immun 2011;25:16-24.
16. Dijk DJ, Duffy JF, Czeisler CA. Contribution of circadian physiology and sleep homeostasis to age-related changes in human sleep. Chronobiol Int 2000;17:285-311.
17. Foley D, Vitiello M, Bliwise D, et al. Frequent napping is associated with excessive daytime sleepiness, depression, pain, and nocturia in older adults. Am J Geriatr Psychiatry 2007;15:344-50.
18. Ohayon MM, Carskadon MA, Guilleminault C, et al. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep 2004;27:1255-73.
19. Leng Y, Wainwright NWJ, Cappuccio FP, et al. Self-reported sleep patterns in a British population cohort. Sleep Med 2014;15:295-302.
20. Day N, Oakes SA, Luben R, et al. EPIC-Norfolk: study design and characteristics of the cohort. Br J Cancer 1999;80:95-103.
21. Ahmadi-Abhari S, Luben RN, Wareham NJ, et al. Distribution and determinants of C-reactive protein in the older adult population: European Prospective Investigation into Cancer-Norfolk study. Eur J Clin Invest 2013;43:899-911.
22. Wareham NJ, Jakes RW, Rennie KL, et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2003;6:407-13.
23. Heslop P, Smith GD, Metcalfe C, et al. Sleep duration and mortality: the effect of short or long sleep duration on cardiovascular and all-cause mortality in working men and women. Sleep Med 2002;3:305-14.
24. Hublin C, Partinen M, Koskenvuo M, et al. Sleep and mortality: a population-based 22-year follow-up study. Sleep 2007;30:1245-53.
25. Bursztyn M. The siesta in the elderly: risk factor for mortality? Arch Intern Med 1999;159:1582-6.
26. Tassi P, Muzet A. Sleep inertia. Sleep Med Rev 2000;4:341-53.
27. Lavie P. Self-reported sleep duration-what does it mean? J Sleep Res 2009;18:385-6.
28. Wium-Andersen MK, Ørsted DD, Nielsen SF, et al. Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals. JAMA Psychiatry 2013;70:176-84.
29. Meier-Ewert HK, Ridker PM, Rifai N, et al. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem 2001;47:426-30.
30. Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010;375:132-40.
31. Naska A, Oikonomou E, Trichopoulou A, et al. Siesta in healthy adults and coronary mortality in the general population. Arch Intern Med 2007;167:296-301.
32. Gao J, Huang X, Park Y, et al. Daytime napping, nighttime sleeping, and Parkinson disease. Am J Epidemiol 2011;173:1032-8.
33. Foley D, Monjan A, Masaki K, et al. Daytime sleepiness is associated with 3-year incident dementia and cognitive decline in older Japanese-American men. J Am Geriatr Soc 2001;49:1628-32.
34. Chen H, O'Reilly EJ, Schwarzschild MA, et al. Peripheral inflammatory biomarkers and risk of Parkinson's disease. Am J Epidemiol 2008;167:90-5.
35. Ferrie JE, Kivimäki M, Akbaraly TN, et al. Associations between change in sleep duration and inflammation: findings on C-reactive protein and interleukin 6 in the Whitehall II study. Am J Epidemiol 2013;178:956-61.
36. Mullington JM, Haack M, Toth M, et al. Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Prog Cardiovasc Dis 2009;51:294-302.
37. Chiu J-J, Usami S, Chien S. Vascular endothelial responses to altered shear stress: pathologic implications for atherosclerosis. Ann Med 2009;41:19-28.
38. Liukkonen T, Räsänen P, Ruokonen A, et al. C-reactive protein levels and sleep disturbances: observations based on the Northern Finland 1966 Birth Cohort study. Psychosom Med 2007;69:756-61.
39. Svensson M, Venge P, Janson C, et al. Relationship between sleep-disordered breathing and markers of systemic inflammation in women from the general population. J Sleep Res 2012;21:147-54.
40. Suarez EC. Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. Brain Behav Immun 2008;22:960-8.
41. Cohen-Mansfield J, Perach R. Sleep duration, nap habits, and mortality in older persons. Sleep 2012;35:1003-9.
42. Ruggiero JS, Redeker NS. Effects of napping on sleepiness and sleep-related performance deficits in night-shift workers: a systematic review. Biol Res Nurs 2014;16:134-42.
43. Allin KH, Bojesen SE, Nordestgaard BG. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 2009;27:2217-24.
44. Campos H, Siles X. Siesta and the risk of coronary heart disease: results from a population-based, case-control study in Costa Rica. Int J Epidemiol 2000;29:429-37.
45. Lam K-BH, Jiang CQ, Thomas GN, et al. Napping is associated with increased risk of type 2 diabetes: the Guangzhou Biobank Cohort Study. Sleep 2010;33:402-7.